Asian Currencies Consolidate; U.S. Tariff Policy Uncertainty May Support
0038 GMT — Asian currencies consolidate against the dollar, but uncertainty over U.S. tariff policy may support. 'One big factor weighing on greenback is the lack of clarity about what the tariffs are ultimately meant to accomplish,' says Matthew Weller, global head of Research at FOREX.com and City Index, in an email. 'Faced with this immense uncertainty on a month-to-month, week-to-week, or even day-to-day basis, forex traders are opting out of owning U.S. dollar at the margin, preferring instead to park their funds in currencies where they have more certainty about future policies,' Weller adds. USD/KRW edges 0.1% higher to 1,439.48; AUD/USD is little changed at 0.6424. (ronnie.harui@wsj.com)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
STATESVILLE, N.C., June 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2025 on Wednesday, June 25, 2025 after the close of trading. This information will be available on the Company's website after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China. Learn more at the companies' websites, located at and This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at and on the SEC website at These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Donald T. Gardner III704/871-3274 View original content to download multimedia: SOURCE Kewaunee Scientific Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
an hour ago
- Business Wire
AM Best Affirms Credit Ratings of Helvetica Re Rückversicherung AG Corporation
BUSINESS WIRE)-- AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of 'a-' (Excellent) of Helvetica Re Rückversicherung AG Corporation (Helvetica) (Barbados). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Helvetica's balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management. The company is Barbados-domiciled and began commercial operations in 2022, underwriting surety for renewable energy and infrastructure developments in Spain seeking further geographic diversification in Latin American markets. Until 2025, the company was originally named Berliner Re Reinsurance Company Inc. The ratings of Helvetica also reflect its strongest level of risk-adjusted capitalization, as measured by Best's Capital Adequacy Ratio (BCAR), adequate reinsurance program and conservative investment strategy aimed at providing liquidity and maintaining appropriate asset-liability management. Partially offsetting these positive rating factors are Helvetica's business profile, which is bounded by its current concentration in a single business line and distribution channel, as well as the highly competitive landscape in its target geographic markets' surety bond segment amid a challenging economic environment. Helvetica's risk-adjusted capitalization stands at the strongest level underpinned by a robust capital base and low underwriting leverage in conjunction with its conservative investment allocation. In AM Best's view, the company's operating performance is pressured by its high administrative expense structure, due to its startup nature; nevertheless, a continuously expanding top line in conjunction with well-contained claims and consistent inflow of investment income is expected to enhance bottom line results within the short term. Helvetica constantly reviews its underwriting guidelines to improve the performance of its businesses. Additionally, reinsurance commissions stemming from its quota share agreement with counterparties with a good level of security, will contribute gradually to offset its high operating expense structure. Helvetica posted a net income of USD 2.3 million within its first year of operation in 2022, followed by USD 8.7 million in 2024, according to preliminary financials. Negative rating actions could occur if Helvetica's high growth levels in conjunction with higher country risk tiers deteriorate balance sheet strength to levels no longer supportive of the strongest level. Additionally, negative rating actions could occur if underwriting results fall short of AM Best's expectations and deteriorate to levels no longer supportive of an adequate operating performance assessment. Positive rating actions, while unlikely within the mid term, could occur if the company is able to achieve geographic expansion successfully, while maintaining premiums sufficiency. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments.
Yahoo
an hour ago
- Yahoo
NIKE's China Recovery Stalls: Can It Regain Its Edge in Asia?
NIKE, Inc. NKE boasts a solid presence in China, which forms a cornerstone in its global growth strategy. The company has strategically invested in China to reinforce its consumer engagement and gain competitive leverage. NIKE's China business, which is commonly referred to as Greater China, delivered revenues of $1.7 billion in third-quarter fiscal 2025, contributing about 15% to total Greater China has remained a challenging market for NIKE, weighed down by a difficult operating environment and tariff-related headwinds. In third-quarter fiscal 2025, Greater China revenues plunged 17% on a reported basis (down 15% in constant currency), as NIKE Direct sales fell 11%, NIKE Digital revenues slid 20% and NIKE-owned store revenues dipped 6%. Wholesale performance also weakened, with an 18% year-over-year decline, underscoring persistent consumer and trade pressures across the near-term challenges, NIKE remains bullish on Greater China's long-term growth potential. To reignite momentum, the company has aggressively cleaned up the marketplace—executing returns and rebates, liquidating excess inventory, and creating space for new product drops and expanded assortments. Management acknowledges China's status as a 'mono-brand market,' and is committed to patience and precision as it phases in its Win Now initiatives, expecting these actions to boost foot traffic and market share over deepens its vast presence in China by customizing product innovation to local tastes, launching culturally resonant marketing campaigns, accelerating research and development activities, and forming strategic alliances with leading Chinese sports and cultural organizations. This concerted effort to embed sport and fitness into everyday life not only deepens consumer engagement but also positions NIKE to outpace competitors in its broader Asian markets. lululemon athletica inc. LULU and adidas AG ADDYY are the key companies competing with NIKE in NKE, lululemon seeks to enhance its presence in China, which is among its key global markets. The company has been experiencing solid momentum in its international markets, especially in China. In first-quarter fiscal 2025, revenues increased 21% in Mainland China (22% in constant currency) while comps improved 8%. The company looks forward to strengthening its physical appearance with constant store openings in the international markets, primarily in China. Amid the tariff-driven pressures, lululemon anticipates revenue growth of 25-30% in Mainland China in fiscal 2025, thanks to its distinct product and innovative solutions. Growth in LULU's customer base through its stores and diverse e-commerce platforms, coupled with product innovations and a robust omnichannel operating model, has been bolstering growth in the is another sporting goods giant vying for a larger share of the Chinese market. The company is aggressively focused on expanding its presence in China by launching locally relevant product lines and enhancing its brand equity via collaborations and marketing campaigns. Amid a highly evolving geopolitical and macroeconomic environment, adidas has been diversifying its supply chain and adopting mitigating strategies. Initiatives like the 'Future City Concept' stores highlight adidas' ongoing commitment to forward retail strategy. Such strategies are likely to offer resilience and sustainability in the long term. Shares of NIKE have lost around 15.5% year to date compared with the industry's decline of 14%. Image Source: Zacks Investment Research From a valuation standpoint, NKE trades at a forward price-to-earnings ratio of 32.5X, higher than the industry's average of 25.76X. Image Source: Zacks Investment Research The Zacks Consensus Estimate for NKE's fiscal 2025 and 2026 earnings implies a year-over-year plunge of 46.1% and 8.7%, respectively. The company's EPS estimate for fiscal 2025 and fiscal 2026 has been stable in the past 30 days. Image Source: Zacks Investment Research NIKE stock currently carries a Zacks Rank #4 (Sell).You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIKE, Inc. (NKE) : Free Stock Analysis Report lululemon athletica inc. (LULU) : Free Stock Analysis Report Adidas AG (ADDYY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research